Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06553911

Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,000 (estimated)
Sponsor
Huashan Hospital · Academic / Other
Sex
All
Age
1 Year – 90 Years
Healthy volunteers
Accepted

Summary

The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an early stage is the premise of all effective measures. AI-MID is a research initiative that uses artificial intelligence tools to assist in the clinical medical imaging diagnosis of respiratory diseases, aiming to reduce the time doctors spend reviewing images, increase work efficiency, and enhance the sensitivity and specificity of pneumonia detection, thereby improving the detection rate of pneumonia at the grassroots level. This approach facilitates precise prevention, accurate diagnosis, and precise treatment.

Conditions

Interventions

TypeNameDescription
OTHERArtificial Intelligence-based medical imaging interpretationIn the AI interpretation group, using clinical information, imaging data, and corresponding etiological results of the study participants, an AI diagnostic tool is established to specifically recognize patients' chest medical imaging and construct corresponding diagnostic conclusions.

Timeline

Start date
2022-04-01
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2024-08-14
Last updated
2024-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06553911. Inclusion in this directory is not an endorsement.